217 related articles for article (PubMed ID: 7712461)
1. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB.
Pei L; Melmed S; Scheithauer B; Kovacs K; Benedict WF; Prager D
Cancer Res; 1995 Apr; 55(8):1613-6. PubMed ID: 7712461
[TBL] [Abstract][Full Text] [Related]
2. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.
Zhang X; Xu HJ; Murakami Y; Sachse R; Yashima K; Hirohashi S; Hu SX; Benedict WF; Sekiya T
Cancer Res; 1994 Aug; 54(15):4177-82. PubMed ID: 8033150
[TBL] [Abstract][Full Text] [Related]
3. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma.
Yoo GH; Xu HJ; Brennan JA; Westra W; Hruban RH; Koch W; Benedict WF; Sidransky D
Cancer Res; 1994 Sep; 54(17):4603-6. PubMed ID: 8062250
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas.
Simpson DJ; Magnay J; Bicknell JE; Barkan AL; McNicol AM; Clayton RN; Farrell WE
Cancer Res; 1999 Apr; 59(7):1562-6. PubMed ID: 10197629
[TBL] [Abstract][Full Text] [Related]
5. Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer.
Tamura K; Zhang X; Murakami Y; Hirohashi S; Xu HJ; Hu SX; Benedict WF; Sekiya T
Int J Cancer; 1997 Feb; 74(1):45-9. PubMed ID: 9036868
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.
Pearce SH; Trump D; Wooding C; Sheppard MN; Clayton RN; Thakker RV
Clin Endocrinol (Oxf); 1996 Aug; 45(2):195-200. PubMed ID: 8881452
[TBL] [Abstract][Full Text] [Related]
7. The retinoblastoma gene is involved in malignant progression of astrocytomas.
Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN
Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217
[TBL] [Abstract][Full Text] [Related]
8. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus.
Zhu J; Leon SP; Beggs AH; Busque L; Gilliland DG; Black PM
J Clin Endocrinol Metab; 1994 Apr; 78(4):922-7. PubMed ID: 8157722
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q.
Kuroki T; Fujiwara Y; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y
Br J Cancer; 1995 Aug; 72(2):383-5. PubMed ID: 7640222
[TBL] [Abstract][Full Text] [Related]
10. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker.
Bates AS; Farrell WE; Bicknell EJ; McNicol AM; Talbot AJ; Broome JC; Perrett CW; Thakker RV; Clayton RN
J Clin Endocrinol Metab; 1997 Mar; 82(3):818-24. PubMed ID: 9062489
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors.
Woloschak M; Roberts JL; Post KD
Cancer; 1994 Jul; 74(2):693-6. PubMed ID: 8033049
[TBL] [Abstract][Full Text] [Related]
12. Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms.
Lai S; Benedict WF; Silver SA; El-Naggar AK
Hum Pathol; 1997 Jun; 28(6):693-7. PubMed ID: 9191003
[TBL] [Abstract][Full Text] [Related]
13. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
Dodson MK; Cliby WA; Xu HJ; DeLacey KA; Hu SX; Keeney GL; Li J; Podratz KC; Jenkins RB; Benedict WF
Cancer Res; 1994 Feb; 54(3):610-3. PubMed ID: 8306318
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
[TBL] [Abstract][Full Text] [Related]
15. Human pituitary adenomas infrequently contain inactivation of retinoblastoma 1 gene and activation of cyclin dependent kinase 4 gene.
Honda S; Tanaka-Kosugi C; Yamada S; Sano T; Matsumoto T; Itakura M; Yoshimoto K
Endocr J; 2003 Jun; 50(3):309-18. PubMed ID: 12940460
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance.
Hu N; Gutsmann A; Herbert DC; Bradley A; Lee WH; Lee EY
Oncogene; 1994 Apr; 9(4):1021-7. PubMed ID: 8134105
[TBL] [Abstract][Full Text] [Related]
17. A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb.
O'Connor DP; Kay EW; Leader M; Murphy GM; Atkins GJ; Mabruk MJ
Mol Pathol; 2001 Jun; 54(3):165-9. PubMed ID: 11376129
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
Ishikawa J; Xu HJ; Hu SX; Yandell DW; Maeda S; Kamidono S; Benedict WF; Takahashi R
Cancer Res; 1991 Oct; 51(20):5736-43. PubMed ID: 1913692
[TBL] [Abstract][Full Text] [Related]
19. Frequent homozygous deletions of D13S218 on 13q14 in B-cell chronic lymphocytic leukemia independent of disease stage and retinoblastoma gene inactivation.
Newcomb EW; Thomas A; Selkirk A; Lee SY; Potmesil M
Cancer Res; 1995 May; 55(10):2044-7. PubMed ID: 7743499
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of molecular genetic changes in sporadic invasive pituitary adenomas.
Nam DH; Song SY; Park K; Kim MH; Suh YL; Lee JI; Kim JS; Hong SC; Shin HJ; Park K; Eoh W; Kim JH
Exp Mol Med; 2001 Sep; 33(3):111-6. PubMed ID: 11642545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
